serine has been researched along with 3-cyano-n-(1,3-diphenyl-1h-pyrazol-5-yl)benzamide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huszar, SL; Hutson, PH; McNaughton, CH; Uslaner, JM; Vardigan, JD | 1 |
1 other study(ies) available for serine and 3-cyano-n-(1,3-diphenyl-1h-pyrazol-5-yl)benzamide
Article | Year |
---|---|
MK-801 produces a deficit in sucrose preference that is reversed by clozapine, D-serine, and the metabotropic glutamate 5 receptor positive allosteric modulator CDPPB: relevance to negative symptoms associated with schizophrenia?
Topics: Allosteric Regulation; Animals; Benzamides; Clozapine; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Male; Pyrazoles; Quinine; Rats; Rats, Wistar; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Schizophrenia; Serine; Sucrose | 2010 |